论文部分内容阅读
近年来,单用分子靶向药物或联合细胞毒药物治疗非小细胞肺癌(NSCLC),其有效性已得到证实,因此,晚期非小细胞肺癌的选择也就更丰富。目前针对分子靶向药物的研究正在进行,在2006年
In recent years, the effectiveness of single-molecule targeted drugs or combination of cytotoxic drugs in the treatment of non-small cell lung cancer (NSCLC) has been confirmed, and therefore the choice of advanced non-small cell lung cancer is also more abundant. The current research on molecular targeted drugs is underway in 2006